The kinetics of G-CSF mobilization of CD34+ cells in healthy people

被引:49
作者
Stroncek, DF
Clay, ME
Herr, G
Smith, J
Jaszcz, WB
Ilstrup, S
McCullough, J
机构
[1] UNIV MINNESOTA,DEPT LAB MED & PATHOL,MINNEAPOLIS,MN 55455
[2] AMER RED CROSS,N CENT BLOOD SERV,ST PAUL,MN
关键词
granulocyte colony-stimulating factor; peripheral blood stem cells; CD34+ cells; bone marrow transplantation;
D O I
10.1046/j.1365-3148.1997.d01-75.x
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
When healthy people are given granulocyte colony stimulating factor (G-CSF) for 10 days the number of CD34+ cells in the peripheral blood begins to increase on the fourth day, reaches a maximum on the sixth day and then decreases. In this study, we further define the time and variability of peak mobilization of CD34+ cells. Twenty-two healthy people were given G-CSF (7.5 or 10 mu g kg(-1) day(-1)) subcutaneously each morning for 5 days and peripheral blood CD34+ cell counts were analysed immediately prior to the fourth (day 4) and fifth (day 5) G-CSF injection and 24 h after the fifth injection (Day 6). White blood cell (WBC) and neutrophil counts were greatest on day 6 [WBC = 43.8 +/- 13.9 x 10(9) L(-1) (mean +/- 1 SD) and neutrophils = 36.6 +/- 12.8 x 10(9) L(-1)]. In contrast the CD34+ cell counts on day 6 (107 +/- 104 x 10(6) L(-1)) were less than on day 5 (128 +/- 136 x 10(6) L(-1)) (P = 0.048) but still greater than on day 4 (60.7 +/- 40.2 x 10(6) L(-1)) (P < 0.0001). The CD34+ cell counts of 10 donors were measured 2, 4 and 6 h after the fifth injection to determine if the counts increased further between days 5 and 6. The number of CD34+ cells in the blood on day 5 2 h after the fifth injection (193 +/- 277 x 10(6) L(-1)) was greater than the number prior to the injection (158 +/- 190 x 10(6) L(-1)), 4 h post-injection (139 +/- 158 x 10(6) L(-1)) and 6 h post-injection (170 +/- 236 x 10(6) L(-1)), but the differences were not significant (P = 0.29, 0.25 and 0.45). The number of CD34+ cells in the blood of 12 people were measured before and after the fourth G-CSF dose. Prior to the day 4 injection the CD34+ count was 61 +/- 40 x 10(6) L(-1). At 2, 4 and 6 h the counts were 60 +/- 40, 61 +/- 29 and 64 +/- 30 x 10(6) L(-1) respectively, and the differences were not significant = 0.99, P = 0.98, and P = 0.73). In conclusion, when healthy volunteers are given daily G-CSF injections, the number of mobilized CD34+ cells was the greatest on day 5, slightly less on day 6 and the least on day 4. If only one PBSC component is needed, PBSCs can be collected on day 5 after only 4 days of G-CSF. If PBSC components are collected on both days 5 and 6, the fifth dose can be given either before or after the collection of the first PBSC component.
引用
收藏
页码:19 / 24
页数:6
相关论文
共 8 条
[1]   TRANSPLANTATION OF ALLOGENEIC PERIPHERAL-BLOOD STEM-CELLS MOBILIZED BY RECOMBINANT HUMAN GRANULOCYTE-COLONY-STIMULATING FACTOR [J].
BENSINGER, WI ;
WEAVER, CH ;
APPELBAUM, FR ;
ROWLEY, S ;
DEMIRER, T ;
SANDERS, J ;
STORB, R ;
BUCKNER, CD .
BLOOD, 1995, 85 (06) :1655-1658
[2]   EFFECTS OF RECOMBINANT HUMAN GRANULOCYTE COLONY-STIMULATING FACTOR ON NEUTROPENIA IN PATIENTS WITH CONGENITAL AGRANULOCYTOSIS [J].
BONILLA, MA ;
GILLIO, AP ;
RUGGEIRO, M ;
KERNAN, NA ;
BROCHSTEIN, JA ;
ABBOUD, M ;
FUMAGALLI, L ;
VINCENT, M ;
GABRILOVE, JL ;
WELTE, K ;
SOUZA, LM ;
OREILLY, RJ .
NEW ENGLAND JOURNAL OF MEDICINE, 1989, 320 (24) :1574-1580
[3]  
KLEIN HG, 1994, STANDARDS BLOOD BANK
[4]   ALLOGENEIC BLOOD STEM-CELL TRANSPLANTATION FOR REFRACTORY LEUKEMIA AND LYMPHOMA - POTENTIAL ADVANTAGE OF BLOOD OVER MARROW ALLOGRAFTS [J].
KORBLING, M ;
PRZEPIORKA, D ;
HUH, YO ;
ENGEL, H ;
VANBESIEN, K ;
GIRALT, S ;
ANDERSSON, B ;
KLEINE, HD ;
SEONG, D ;
DEISSEROTH, AB ;
ANDREEFF, M ;
CHAMPLIN, R .
BLOOD, 1995, 85 (06) :1659-1665
[5]  
SATO N, 1994, EXP HEMATOL, V22, P973
[6]   PRIMARY TRANSPLANTATION OF ALLOGENEIC PERIPHERAL-BLOOD PROGENITOR CELLS MOBILIZED BY FILGRASTIM (GRANULOCYTE-COLONY-STIMULATING FACTOR) [J].
SCHMITZ, N ;
DREGER, P ;
SUTTORP, M ;
ROHWEDDER, EB ;
HAFERLACH, T ;
LOFFLER, H ;
HUNTER, A ;
RUSSELL, NH .
BLOOD, 1995, 85 (06) :1666-1672
[7]   Treatment of normal individuals with granulocyte-colony-stimulating factor: Donor experiences and the effects on peripheral blood CD34+ cell counts and on the collection of peripheral blood stem cells [J].
Stroncek, DF ;
Clay, ME ;
Petzoldt, ML ;
Smith, J ;
Jaszcz, W ;
Oldham, FB ;
McCullough, J .
TRANSFUSION, 1996, 36 (07) :601-610
[8]  
TJENNFJORD GE, 1994, BLOOD, V84, P2796